Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Braunstein Douglas L
Relationship:  
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   3,704,541    

Indirect Shares

  35,908,536      
Direct Value   $102,375,744    

Indirect Value

  $614,125,084      
Total Shares   39,613,077      
Total Value   $716,500,828      


JP Morgan Chase & Co
 $93,371,487 Cantaloupe Inc
 $135,016 Talkspace, Inc
 $8,869,241 JP Morgan Chase & Co
 $93,371,487 Cantaloupe Inc
 $135,016 Talkspace, Inc
 $8,869,241
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    9   
    1    

     Stock price went up :

    3   
    1    
     Stock price went down :
    6   
    0    
   
     Gain/Loss Ratio :
   0.0   
   1.0   
     Percentage Gain/Loss :
   -41.0%
 14.8%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            JP Morgan Chase & Co JPM Chief Financial Officer 2012-12-26 470,836 2012-12-26 109,479    Premium*  
            Eagle Pharmaceuticals, Inc. EGRX Director 0 2019-10-25 732,777    Premium*  
            Corindus Vascular Robotics, Inc. CVRS Director 2019-10-29 0 2019-10-29 0    Premium*  
            Cardtronics Inc CATM 10% Owner 2018-02-21 0 2021-03-09 8,658,920    Premium*  
            Cantaloupe Inc CTLP 10% Owner 2023-02-21 20,212 2023-02-21 9,270,694    Premium*  
            Tivity Health Inc TVTY 10% Owner 0 2020-05-07 4,795,310    Premium*  
            Talkspace, Inc TALK 2024-03-01 3,213,493 2024-03-01 12,341,356    Premium*  
* Premium Members only  

Records found :    91         Free Registration Required For Full Results.    Limit: 25

Download
  Page 4 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
EGRX Eagle Pharmaceuticals, In... Director   –       •      –    2019-09-17 4 AS $60.00 $6,000 I/I (100) 810,365 0 -
EGRX Eagle Pharmaceuticals, In... Director   –       •      –    2019-10-08 4 AS $60.03 $93,520 I/I (1,558) 803,906 0 -
EGRX Eagle Pharmaceuticals, In... Director   –       •      –    2019-09-11 4 AS $60.06 $66,785 I/I (1,112) 810,665 0 -
EGRX Eagle Pharmaceuticals, In... Director   –       •      –    2019-09-12 4 AS $60.07 $12,014 I/I (200) 810,465 0 -
EGRX Eagle Pharmaceuticals, In... Director   –       •      –    2019-10-07 4 AS $60.11 $294,600 I/I (4,901) 805,464 0 -
EGRX Eagle Pharmaceuticals, In... Director   –       •      –    2019-10-10 4 AS $60.16 $471,002 I/I (7,829) 796,077 0 -
EGRX Eagle Pharmaceuticals, In... Director   –       •      –    2019-10-11 4 AS $60.39 $984,419 I/I (16,300) 779,777 0 -
EGRX Eagle Pharmaceuticals, In... 10% Owner   –       –       •   2019-10-16 4 AS $62.50 $6,375 I/I (102) 775,766 0 -
EGRX Eagle Pharmaceuticals, In... Director   –       •      –    2019-10-24 4 AS $62.53 $93,412 I/I (1,494) 748,214 0 -
EGRX Eagle Pharmaceuticals, In... Director   –       •      –    2019-10-21 4 AS $62.56 $240,791 I/I (3,849) 756,475 0 -
EGRX Eagle Pharmaceuticals, In... 10% Owner   –       –       •   2019-10-17 4 AS $62.58 $866,196 I/I (13,842) 761,924 0 -
EGRX Eagle Pharmaceuticals, In... Director   –       •      –    2019-10-23 4 AS $62.58 $12,516 I/I (200) 749,708 0 -
EGRX Eagle Pharmaceuticals, In... 10% Owner   –       –       •   2019-10-18 4 AS $62.61 $100,174 I/I (1,600) 760,324 0 -
EGRX Eagle Pharmaceuticals, In... Director   –       •      –    2019-10-15 4 AS $62.63 $244,836 I/I (3,909) 775,868 0 -
EGRX Eagle Pharmaceuticals, In... Director   –       •      –    2019-10-22 4 AS $62.68 $411,618 I/I (6,567) 749,908 0 -
EGRX Eagle Pharmaceuticals, In... Director   –       •      –    2019-10-25 4 AS $63.57 $981,302 I/I (15,437) 732,777 0 -

  91  Records found
  1   2   3   4     
  Page 4 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed